Explore the Site

  • Latest News
  • AusBiotech
  • Events
  • About
  • Contact
  • Subscribe
  • Search

Follow Us

  • LinkedIn
  • Twitter
  • Instagram
BiotechDispatch Menu
April 21, 2021
  • Subscribe
  • Login
  • Latest News
  • AusBiotech
  • Events
  • About
  • Contact
  • Subscribe
  • Search

Sign In

  • Forgot password?
  • Latest News

    Exopharm completes $12 million capital raise

    April 20, 2021
  • AusBiotech

    AusBiotech appoints new director - Dr James Campbell

    April 20, 2021
  • Australian medtech consultancy merges with international leader

    April 20, 2021
  • Latest News Telix launches international NOBLE Registry of SPECT-Based prostate cancer imaging agent April 20, 2021
    Telix has announced the launch of the international NOBLE Registry of its ‘rest of world’ prostate cancer imaging agent and the dosing of the first patient.
  • Latest News Race Oncology appoints chief medical officer April 20, 2021
    Race Oncology (ASX:RAC) has announced the appointment of Dr David Fuller as its chief medical officer.
  • Latest News Pharmaxis sells Bronchitol rights in Russia and completes placement April 15, 2021
    Australian company Pharmaxis has sold Russian distribution rights to cystic fibrosis therapy BRONCHITOL (mannitol) and completed a $4.4 million placement to institutional investors.
  • AusBiotech CSL’s Plasma Protein Purification Challenge opens April 15, 2021
    CSL Behring and Cicada Innovations’ new Plasma Protein Purification Challenge seeks to tackle some of the biggest challenges in plasma protein production and to save and improve lives.
  • Latest News Alcidion Group acquires UK company and confirms capital raise April 15, 2021
    Informatics company Alcidion Group (ASX:ALC) has announced its acquisition of UK company ExtraMed, provided an update on its growth and released details of a $17.9 million capital raise.
  • Latest News Ex-AusBiotech CEO joins board of emerging local biotech April 15, 2021
    Adelaide-based Australian biotechnology company Sementis has appointed former AusBiotech CEO and Medicines Australia chair Dr Anna Lavelle as an independent director.
  • Latest News Amplia completes dosing in phase one study of AMP945 April 15, 2021
    Amplia Therapeutics (ASX:ATX), a company developing new drugs for the treatment for cancer and fibrosis, has announced it has successfully completed the dosing of subjects in its phase one clinical trial of its focal adhesion kinase inhibitor AMP945.
  • Latest News Zelira announces record revenue in the march quarter April 15, 2021
    Zelira Therapeutics (ASX:ZLD) says it generated record quarterly product sales and licensing revenues of $225,000 for the March 2021 quarter, up 249 per cent from the previous six months.
  • Latest News Australian-led discovery could speed up bone implant recovery April 13, 2021
    An international research team led by Monash University has uncovered a new technique it says could speed up recovery from bone replacements by altering the shape and nucleus of individual stem cells.
  • AusBiotech AusBiotech responds to university research commercialisation consultation April 13, 2021
    AusBiotech united voices across the biotech pipeline as it responded to the University Research Commercialisation consultation and provided views on how any new scheme must be set in the context of a strategic long-term national objective.
  • Latest News European approval for AnteoTech's COVID-19 test April 13, 2021
    AnteoTech (ASX:ADO) has announced it has received CE Mark registration for its EuGeni Reader and the in vitro rapid diagnostic test for the detection of SARS-CoV-2 nucleocapsid antigen, the COVID-19 ART.
  • Latest News Approval to start trial of new Australian COVID-19 vaccine April 13, 2021
    The consortium has announced they have received ethics approval for an Australian phase one clinical trial of the COVIGEN COVID-19 vaccine candidate.
  • Latest News Genetic Technologies appoints new chief financial officer April 13, 2021
    Molecular diagnostics company Genetic Technologies (ASX:GTG)  has announced the appointment of Michael Tonroe as its new chief financial officer.

Most Read

  • Australian medtech consultancy merges with international leader

    April 20, 2021
  • AusBiotech appoints new director - Dr James Campbell

    April 20, 2021 - AusBiotech
  • Exopharm completes $12 million capital raise

    April 20, 2021 - Latest News
  • Race Oncology appoints chief medical officer

    April 20, 2021 - Latest News
  • Telix launches international NOBLE Registry of SPECT-Based prostate cancer imaging agent

    April 20, 2021 - Latest News

Follow Us

  • LinkedIn
  • Twitter
  • Instagram

New Stories

  • Telix launches international NOBLE Registry of SPECT-Based prostate cancer imaging agent

    April 20, 2021 - - Latest News
  • Australian medtech consultancy merges with international leader

    April 20, 2021 -
  • Exopharm completes $12 million capital raise

    April 20, 2021 - - Latest News
  • Race Oncology appoints chief medical officer

    April 20, 2021 - - Latest News
  • AusBiotech appoints new director - Dr James Campbell

    April 20, 2021 - - AusBiotech
  • Pharmaxis sells Bronchitol rights in Russia and completes placement

    April 15, 2021 - - Latest News
  • Ex-AusBiotech CEO joins board of emerging local biotech

    April 15, 2021 - - Latest News
  • About Us
  • Contact Us
  • Privacy Policy
  • Subscribe
  • Powered by Newsroom

©2021 DailyDispatch Pty Ltd. All Rights Reserved.